Poly(lactic acid/caprolactone) bilayer membrane blocks bacterial penetration

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Oral Surgery

Background:

• Postoperative infections can impair clinical outcomes of guided bone regeneration (GBR) and guided tissue regeneration (GTR).
• Membrane exposure is a common cause of bacterial infection at surgical sites.
• A poly(lactic acid/caprolactone) (PLCL) bilayer membrane was previously developed with a compact layer hypothesized to act as a bacterial barrier.

Purpose of the Study:

• To evaluate the efficacy of the PLCL bilayer membrane in preventing bacterial cell penetration.
• To assess the potential of the PLCL membrane in preventing postoperative infections in GTR/GBR procedures.

Main Methods:

• Bacterial adhesion and penetration assays were performed using Porphyromonas gingivalis, Streptococcus mutans, and multispecies bacteria.
• Bacteria were seeded on the compact layer of the PLCL bilayer membrane and control membranes (poly(lactic-co-glycolic acid) or type I collagen).
• Bacterial adhesion was quantified by colony counts, and penetration was visualized using scanning electron microscopy.

Main Results:

• All tested bacteria adhered to membranes within 6 hours, but the PLCL membrane showed significantly reduced adhesion compared to controls.
• The PLCL membrane effectively blocked bacterial penetration, with no cells observed within its structure.
• Control membranes allowed bacterial penetration up to 80 µm after 72 hours.

Conclusions:

• The PLCL bilayer membrane exhibits reduced bacterial adhesion and superior bacterial penetration blocking capabilities.
• These properties suggest the PLCL membrane can contribute to favorable outcomes in regenerative treatments by preventing infection.
• The PLCL membrane's barrier function could simplify the management of complications arising from membrane exposure in GTR/GBR surgeries.